Logo image of MRDB

MARIADB PLC (MRDB) Stock Fundamental Analysis

NYSE:MRDB - New York Stock Exchange, Inc. - IE0008908NI4 - Common Stock - Currency: USD

0.5494  +0 (+0.7%)

After market: 0.5476 0 (-0.33%)

Fundamental Rating

1

Overall MRDB gets a fundamental rating of 1 out of 10. We evaluated MRDB against 283 industry peers in the Software industry. MRDB may be in some trouble as it scores bad on both profitability and health. MRDB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

MRDB had negative earnings in the past year.
In the past year MRDB has reported a negative cash flow from operations.
MRDB Yearly Net Income VS EBIT VS OCF VS FCFMRDB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -10M -20M -30M -40M -50M

1.2 Ratios

MRDB has a Return On Assets of -155.23%. This is amonst the worse of the industry: MRDB underperforms 94.01% of its industry peers.
Industry RankSector Rank
ROA -155.23%
ROE N/A
ROIC N/A
ROA(3y)-57.55%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MRDB Yearly ROA, ROE, ROICMRDB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 100 -100

1.3 Margins

MRDB has a Gross Margin of 76.09%. This is in the better half of the industry: MRDB outperforms 72.18% of its industry peers.
MRDB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MRDB Yearly Profit, Operating, Gross MarginsMRDB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 50 -50

More info and screens

0

2. Health

2.1 Basic Checks

MRDB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MRDB has been increased compared to 1 year ago.
MRDB has a worse debt/assets ratio than last year.
MRDB Yearly Shares OutstandingMRDB Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 20M 40M 60M
MRDB Yearly Total Debt VS Total AssetsMRDB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

MRDB has an Altman-Z score of -15.52. This is a bad value and indicates that MRDB is not financially healthy and even has some risk of bankruptcy.
MRDB's Altman-Z score of -15.52 is on the low side compared to the rest of the industry. MRDB is outperformed by 91.90% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -15.52
ROIC/WACCN/A
WACC10.3%
MRDB Yearly LT Debt VS Equity VS FCFMRDB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.38 indicates that MRDB may have some problems paying its short term obligations.
The Current ratio of MRDB (0.38) is worse than 94.72% of its industry peers.
A Quick Ratio of 0.38 indicates that MRDB may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.38, MRDB is doing worse than 94.72% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.38
MRDB Yearly Current Assets VS Current LiabilitesMRDB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for MRDB have decreased strongly by -1850.11% in the last year.
Looking at the last year, MRDB shows a very strong growth in Revenue. The Revenue has grown by 321.09%.
EPS 1Y (TTM)-1850.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.05%
Revenue 1Y (TTM)321.09%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%6.3%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MRDB Yearly Revenue VS EstimatesMRDB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 10M 20M 30M 40M 50M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MRDB. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MRDB Price Earnings VS Forward Price EarningsMRDB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MRDB Per share dataMRDB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MRDB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MARIADB PLC

NYSE:MRDB (8/23/2024, 8:04:01 PM)

After market: 0.5476 0 (-0.33%)

0.5494

+0 (+0.7%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-14 2024-08-14/amc
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change157058000%
Ins Owners107.86%
Ins Owner Change0%
Market Cap37.91M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.7
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.71
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS0.78
BVpS-0.79
TBVpS-0.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -155.23%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.09%
FCFM N/A
ROA(3y)-57.55%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.75
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.38
Quick Ratio 0.38
Altman-Z -15.52
F-Score3
WACC10.3%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1850.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.05%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)321.09%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%6.3%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-181.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-3484.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3483.88%
OCF growth 3YN/A
OCF growth 5YN/A